Serum magnesium level as a predictive tool for preterm labour
نویسندگان
چکیده
منابع مشابه
Serum magnesium level in preterm labour.
Preterm labour, (PTL) defined as labour after 28 weeks but before 37 completed week of gestation, is an ill omen for our country as the incidence is 5-10% leading to 70-80% of perinatal deaths. Besides varied etiology, it may be due to alteration in basic biochemical functions of the body at cellular level stating emphasis to trace elements, of which magnesium, being one of them, is subject of ...
متن کاملSerum Ferritin Level in Preterm Labour
Objective: The aim of this study was to investigate causal association of serum ferritin with pre-term labour. Materials and Methods: This is a case-control study done on one hundred and twenty women from July 2005 to June 2007 in the department of obstetrics and gynecology of Bangabandhu Sheikh Mujib Medical University (BSMMU) and Mother and Child Health Training Institute (MCHTI), Azimpur, Dh...
متن کاملA Study on the Association between Low Maternal Serum Magnesium Level and Preterm Labour.
Objectives. The study was aimed to assess the association between low maternal serum magnesium levels and preterm labour. Methods. It is a cross-sectional case-control study in which eligible participants were pregnant women admitted in labour within the labour ward complex of a Lagos tertiary hospital. Relevant data were extracted from the case records of these women and blood samples were obt...
متن کاملMagnesium sulphate for preventing preterm birth in threatened preterm labour.
BACKGROUND Magnesium sulphate has been used in some settings as a tocolytic agent to inhibit uterine activity in women in preterm labour with the aim of preventing preterm birth. OBJECTIVES To assess the effects of magnesium sulphate therapy given to women in threatened preterm labour with the aim of preventing preterm birth and its sequelae. SEARCH METHODS We searched the Cochrane Pregnanc...
متن کاملPDE4 as a target in preterm labour
Cyclic nucleotide phosphodiesterases (PDE) are the enzymes catalyzing the hydrolysis and inactivation of the second messengers, cAMP and cGMP. Eleven PDE families are described to date, and selective inhibitors of some PDEs families are currently used in clinic for treating cardiovascular disorders, erectile dysfunction, and pulmonary hypertension. Isoforms of the PDE4 family are involved in sm...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Obstetrics and Gynecology Research
سال: 2020
ISSN: 2394-2746,2394-2754
DOI: 10.18231/j.ijogr.2020.077